ATE272395T1 - Präparationen zur kontrollierten freisetzung - Google Patents

Präparationen zur kontrollierten freisetzung

Info

Publication number
ATE272395T1
ATE272395T1 AT99919574T AT99919574T ATE272395T1 AT E272395 T1 ATE272395 T1 AT E272395T1 AT 99919574 T AT99919574 T AT 99919574T AT 99919574 T AT99919574 T AT 99919574T AT E272395 T1 ATE272395 T1 AT E272395T1
Authority
AT
Austria
Prior art keywords
release
controlled
controlled release
release preparations
drug
Prior art date
Application number
AT99919574T
Other languages
English (en)
Inventor
Hiroyuki Maeda
Yutaka Ogawa
Yoshimitsu Iida
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE272395T1 publication Critical patent/ATE272395T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99919574T 1998-05-15 1999-05-14 Präparationen zur kontrollierten freisetzung ATE272395T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13321998 1998-05-15
PCT/JP1999/002499 WO1999059552A1 (en) 1998-05-15 1999-05-14 Regulated release preparations

Publications (1)

Publication Number Publication Date
ATE272395T1 true ATE272395T1 (de) 2004-08-15

Family

ID=15099526

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99919574T ATE272395T1 (de) 1998-05-15 1999-05-14 Präparationen zur kontrollierten freisetzung

Country Status (10)

Country Link
US (1) US6544554B1 (de)
EP (1) EP1077065B1 (de)
JP (1) JP5048177B2 (de)
KR (1) KR100630290B1 (de)
CN (1) CN1211078C (de)
AT (1) ATE272395T1 (de)
AU (1) AU748359B2 (de)
DE (1) DE69919155T2 (de)
TW (1) TW592730B (de)
WO (1) WO1999059552A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6837696B2 (en) 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
NZ532096A (en) 2001-09-28 2006-10-27 Mcneil Ppc Inc Dosage forms having an inner core and outer shell with different shapes
WO2004024188A1 (ja) * 2002-09-12 2004-03-25 Nihon Medi-Physics Co., Ltd. 薬物の血漿蛋白質結合を制御するための製剤
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
GB0400031D0 (en) 2004-01-03 2004-02-04 Univ Sheffield Depression treatment
FR2872705B1 (fr) * 2004-07-08 2008-07-18 Aventis Pharma Sa Compositions contenant du nicorandil, procede de preparation et utilisation
ITMI20041689A1 (it) 2004-09-01 2004-12-02 Bojidar Mihaylov Stankov Nuove formulazioni di rilascio controllato contenenti 5-idrossitriptofano e triptofano
US8022032B2 (en) 2004-11-19 2011-09-20 Smithkline Beecham Corporation Method for customized dispensing of variable dose drug combination products for individualizing of therapies
US6980471B1 (en) * 2004-12-23 2005-12-27 Sandisk Corporation Substrate electron injection techniques for programming non-volatile charge storage memory cells
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
KR101118866B1 (ko) * 2008-11-28 2012-03-19 한올바이오파마주식회사 박동성 방출 제제 및 그 제조방법
WO2012162492A1 (en) * 2011-05-24 2012-11-29 Teva Pharmaceutical Industries Ltd. Compressed core comprising organic acids for a pharmaceutical composition
US10596127B2 (en) 2013-03-14 2020-03-24 Wellesley Pharmaceuticals, Llc Composition for reducing the frequency of urination, method of making and use thereof
EP3355877A4 (de) * 2015-09-30 2019-05-15 Wellesley Pharmaceuticals, LLC Zusammensetzung zur verminderung der urinierungshäufigkeit, verfahren zur herstellung und verwendung davon
WO2020214879A1 (en) * 2019-04-19 2020-10-22 Steven Hoffman Sustained release formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
KR940000232B1 (ko) * 1986-01-17 1994-01-12 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 제제의 안정화 방법
JP2638604B2 (ja) * 1987-03-24 1997-08-06 中外製薬株式会社 徐放性製剤
US5057317A (en) * 1987-03-24 1991-10-15 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
US5188836A (en) * 1990-07-27 1993-02-23 Warner-Lambert Company Sustained release formulations
JP2535141B2 (ja) 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili

Also Published As

Publication number Publication date
KR20010043538A (ko) 2001-05-25
US6544554B1 (en) 2003-04-08
EP1077065A1 (de) 2001-02-21
EP1077065B1 (de) 2004-08-04
DE69919155D1 (de) 2004-09-09
WO1999059552A1 (en) 1999-11-25
KR100630290B1 (ko) 2006-09-29
JP5048177B2 (ja) 2012-10-17
TW592730B (en) 2004-06-21
EP1077065A4 (de) 2002-03-13
AU3730099A (en) 1999-12-06
AU748359B2 (en) 2002-06-06
DE69919155T2 (de) 2005-08-04
CN1211078C (zh) 2005-07-20
CN1301151A (zh) 2001-06-27

Similar Documents

Publication Publication Date Title
ATE272395T1 (de) Präparationen zur kontrollierten freisetzung
PT841903E (pt) Composicao farmaceutica oral contendo agentes activos antimicrobianos e pantoprazole com libertacao diferida
MXPA03003895A (es) Formulaciones de hidrocodona de liberacion controlada.
NO20022014L (no) En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon
DE59207438D1 (de) Pantoprazol enthaltende orale darreichungsformen
DE69941115D1 (de) Tablette mit einzelnem kern zur oralen verabreichung mit kontrollierter freisetzung
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
DE69938791D1 (de) Orale methylphenidat-formulierungen mit kontrollierter/veränderter freisetzung
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
NO20004823D0 (no) Nye galeniske formuleringer av meloksicam for oral administrering
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
SE9704869D0 (sv) New pharmaceutical formulaton II
DE69003347D1 (de) Elemente mit protrahierter Wirkstoffabgabe.
NO20013060L (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
PT885014E (pt) Composicoes farmaceuticas contendo polimeros orto ester tamponados
DE3681021D1 (de) Arzneimittelzubereitung mit verzoegerter freisetzung.
NO884052L (no) Fremgangsmaate for fremstilling av terapeutisk preparat.
NO985299D0 (no) Preparat av prostaglandin I-derivat med langsom frigj°ring
ATE220547T1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
JP2002542281A5 (de)
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
NO892512D0 (no) Oralt preparat av buspiron og salter derav.
MEP55908A (en) Utilzation of powder preparations containig hydroxypvridones for treating leg ulcers and decubitus ulcers
UY24780A1 (es) Composiciones farmacéuticas estabilizadas a base de quinupristina y dalfopristina y su preparación.
ATE288269T1 (de) Arzneizusammensetzungen und herstellungsverfahren von ergotalkaloidhaltigen arzneizusammensetzungen mit verzögerter wirkstoffabgabe und verbesserter bioverfügbarkeit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties